R. YILDIZ Et Al. , "Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience," TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.3, pp.231-241, 2022
YILDIZ, R. Et Al. 2022. Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.3 , 231-241.
YILDIZ, R., Selim, Y., Demirel, D., Dilsad, V. D., Mungan, B. A., AYDIN, Ö., ... SİN, B. A.(2022). Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience. TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.3, 231-241.
YILDIZ, REYHAN Et Al. "Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience," TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.3, 231-241, 2022
YILDIZ, REYHAN Et Al. "Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience." TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.3, pp.231-241, 2022
YILDIZ, R. Et Al. (2022) . "Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience." TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.70, no.3, pp.231-241.
@article{article, author={REYHAN YILDIZ Et Al. }, title={Incidence and clinical course of COVID-19 in patients using omalizumab for chronic spontaneous urticaria and/or severe allergic asthma and using mepolizumab for severe eosinophilic asthma: A single center real life experience}, journal={TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX}, year=2022, pages={231-241} }